UY23240A1 - Procedimiento para la preparacion de una composicion farmaceutica inyectable - Google Patents

Procedimiento para la preparacion de una composicion farmaceutica inyectable

Info

Publication number
UY23240A1
UY23240A1 UY23240A UY23240A UY23240A1 UY 23240 A1 UY23240 A1 UY 23240A1 UY 23240 A UY23240 A UY 23240A UY 23240 A UY23240 A UY 23240A UY 23240 A1 UY23240 A1 UY 23240A1
Authority
UY
Uruguay
Prior art keywords
procedure
preparation
pharmaceutical composition
active substance
injectable pharmaceutical
Prior art date
Application number
UY23240A
Other languages
English (en)
Inventor
Flores Josue Garza
Soto Laura P Laiseca
Pichardo Jose Guillen
Uribe Juan Angeles
Original Assignee
Aplicaciones Farm S A De C V
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aplicaciones Farm S A De C V filed Critical Aplicaciones Farm S A De C V
Publication of UY23240A1 publication Critical patent/UY23240A1/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682Processes
    • A61K9/1694Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682Processes
    • A61K9/1688Processes resulting in pure drug agglomerate optionally containing up to 5% of excipient
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/02Nutrients, e.g. vitamins, minerals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nutrition Science (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Steroid Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)

Abstract

Procedimiento para mejorar el control de las propiedades farmacocinéticas y farmacológicas de una sustancia farmacéuticamente activa inyectable, que consiste en poner dicha sustancia en forma de microesferas sólidas, no porosas, con diámetro entre 1 y 300 micrómetros y separar dichas microesferas y fracciones calibradas de acuerdo con sus diámetros. La sustancia farmacológicamente activa se selecciona entre los esteroides, principalmentela progesterona y el 17-beta-estradiol; o la sustancia farmacéuticamente activa se selecciona entre los analgésicos, principalmente naproxen y la indometacina.
UY23240A 1990-06-14 1991-06-13 Procedimiento para la preparacion de una composicion farmaceutica inyectable UY23240A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9007416A FR2663223B1 (fr) 1990-06-14 1990-06-14 Forme galenique parenterale.

Publications (1)

Publication Number Publication Date
UY23240A1 true UY23240A1 (es) 1991-07-12

Family

ID=9397598

Family Applications (1)

Application Number Title Priority Date Filing Date
UY23240A UY23240A1 (es) 1990-06-14 1991-06-13 Procedimiento para la preparacion de una composicion farmaceutica inyectable

Country Status (30)

Country Link
US (3) US5360616A (es)
EP (1) EP0533739B1 (es)
JP (1) JP2675675B2 (es)
KR (1) KR0157439B1 (es)
CN (1) CN1057442C (es)
AT (1) ATE109658T1 (es)
AU (1) AU661275B2 (es)
BG (1) BG61179B1 (es)
BR (1) BR9106545A (es)
CA (1) CA2085344C (es)
CZ (1) CZ286793B6 (es)
DE (1) DE69103419T2 (es)
DK (1) DK0533739T3 (es)
ES (1) ES2059142T3 (es)
FI (1) FI107698B (es)
FR (1) FR2663223B1 (es)
HU (1) HUT68709A (es)
IE (1) IE62679B1 (es)
IL (1) IL98459A (es)
NO (1) NO302998B1 (es)
NZ (1) NZ238542A (es)
PL (1) PL167234B1 (es)
PT (1) PT97975B (es)
RU (1) RU2104692C1 (es)
SK (1) SK280564B6 (es)
TN (1) TNSN91048A1 (es)
UA (1) UA27043C2 (es)
UY (1) UY23240A1 (es)
WO (1) WO1991019484A1 (es)
ZA (1) ZA914550B (es)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2663224B1 (fr) * 1990-06-14 1995-01-20 Applicationes Farmaceuticas Sa Forme galenique parenterale.
GB9313642D0 (en) * 1993-07-01 1993-08-18 Glaxo Group Ltd Method and apparatus for the formation of particles
FR2732621B1 (fr) * 1995-04-10 1997-06-06 Rhone Poulenc Chimie Perles d'un produit presentant le phenomene de surfusion et leur procede d'obtention
US5904935A (en) * 1995-06-07 1999-05-18 Alza Corporation Peptide/protein suspending formulations
US6028057A (en) * 1998-02-19 2000-02-22 Thorn Bioscience, Llc Regulation of estrus and ovulation in gilts
US6287693B1 (en) * 1998-02-25 2001-09-11 John Claude Savoir Stable shaped particles of crystalline organic compounds
CA2321924A1 (en) * 1998-02-25 1999-09-02 Abbott Laboratories Butorphanol sustained release formulations
WO2001013885A1 (en) * 1999-08-20 2001-03-01 Norton Healthcare Ltd. Method to produce powders for pulmonary or nasal administration
US20070254008A1 (en) * 2001-07-13 2007-11-01 Flow Focusing, Inc. Antibiotic formulation and method of treatment
US20070254009A1 (en) * 2001-07-13 2007-11-01 Flow Focusing, Inc. Antibiotic/bone morphogenic protein formulation and method of treatment
US20030055075A1 (en) * 2001-07-13 2003-03-20 Rubsamen Reid M. Programmable controlled release injectable opioid formulation
GB0117696D0 (en) * 2001-07-20 2001-09-12 Bradford Particle Design Plc Particle information
EP1820494B1 (en) * 2003-06-13 2010-01-13 Skendi Finance, Ltd. Microparticles consisting of estradiol and cholesterol
US20050032811A1 (en) 2003-08-06 2005-02-10 Josiah Brown Methods for administering aripiprazole
SI1660009T1 (sl) 2003-09-03 2015-07-31 Miscon Trading S.A. Metode za zdravljenje endometrioze
EP3025722B1 (en) * 2003-10-03 2020-05-27 Thorn BioScience, LLC Process for the synchronization of ovulation for timed breeding without heat detection
JP4836797B2 (ja) 2003-10-23 2011-12-14 大塚製薬株式会社 放出制御性無菌注射アリピプラゾール製剤および方法
US7413690B1 (en) 2003-10-29 2008-08-19 The University Of Mississippi Process and apparatus for producing spherical pellets using molten solid matrices
US7491263B2 (en) * 2004-04-05 2009-02-17 Technology Innovation, Llc Storage assembly
US7392635B2 (en) * 2005-06-09 2008-07-01 Tipper Tie, Inc. Breech loader packaging systems and associated breech loading chutes and methods
US20070197435A1 (en) * 2006-02-17 2007-08-23 Webel Stephen K Process for the synchronization of ovulation for timed breeding without heat detection
WO2008054725A2 (en) 2006-10-31 2008-05-08 Surmodics Pharmaceuticals, Inc. Spheronized polymer particles
DK2170279T3 (en) 2007-07-31 2018-03-12 Otsuka Pharma Co Ltd PROCEDURES FOR PREPARING AN ARIPIPRAZOL SUSPENSION AND A FREEZER DRIED FORMULATION
CN102056611A (zh) * 2008-04-14 2011-05-11 Posi维森纳里解决方案有限责任公司 用于获得不同的治疗适应症所需要的血浆孕酮水平的方法和药物组合物
PL2421545T3 (pl) 2009-04-23 2018-05-30 Jbs United Animal Health Ii Llc Sposób i kompozycja do synchronizacji czasu inseminacji
UY33103A (es) * 2009-12-15 2011-07-29 Techsphere S A De C V Formulacion farmaceutica parenteral en suspension, de liberacion sostenida, en dosis baja y ultra baja, en terapia hormonal en el sindrome climaterico
WO2014085674A1 (en) 2012-11-28 2014-06-05 Jbs United Animal Health Ii Llc Method for synchronizing time of insemination in gilts
WO2017105512A1 (en) 2015-12-18 2017-06-22 Proinvet Innovations S.A. Formulations and methods for controlling the reproductive cycle and ovulation
WO2017147274A1 (en) * 2016-02-24 2017-08-31 Eastern Virginia Medical School An improved formulation of long-acting levonorgestrel butanoate injectable depot suspension
CN106063783B (zh) * 2016-06-16 2019-03-12 浙江爱生药业有限公司 一种黄体酮缓释微囊制剂及其制备方法
US11376220B2 (en) 2017-06-30 2022-07-05 Therio, LLC Single-injection methods and formulations to induce and control multiple ovarian follicles in bovine, caprine, ovine, camelid and other female animals
CN115212170B (zh) * 2021-04-19 2024-01-26 中国人民解放军军事科学院军事医学研究院 一种致密圆整的药物球形微晶及其制备方法和其应用

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE670438A (es) * 1964-10-06 1966-01-31
US3773919A (en) * 1969-10-23 1973-11-20 Du Pont Polylactide-drug mixtures
US3928566A (en) * 1970-08-14 1975-12-23 Du Pont Lyophilized biological products
JPS5017525A (es) * 1973-06-14 1975-02-24
CA1077842A (en) * 1975-10-09 1980-05-20 Minnesota Mining And Manufacturing Company Albumin medicament carrier system
US4244949A (en) * 1978-04-06 1981-01-13 The Population Council, Inc. Manufacture of long term contraceptive implant
US4349580A (en) * 1978-08-18 1982-09-14 Queen's University At Kingston Process and solution for preserving green plant tissues
US4384975A (en) * 1980-06-13 1983-05-24 Sandoz, Inc. Process for preparation of microspheres
US4349530A (en) * 1980-12-11 1982-09-14 The Ohio State University Implants, microbeads, microcapsules, preparation thereof and method of administering a biologically-active substance to an animal
US4963367A (en) * 1984-04-27 1990-10-16 Medaphore, Inc. Drug delivery compositions and methods
IL79407A (en) * 1985-08-01 1991-03-10 Theragenics Corp System and method for delivering insoluble material into a living body
ES2039219T3 (es) * 1986-08-11 1993-09-16 American Cyanamid Company Composiciones para administracion parenteral y su uso.
US4837381A (en) * 1986-08-11 1989-06-06 American Cyanamid Company Compositions for parenteral administration and their use
US4892734A (en) * 1987-04-06 1990-01-09 Endocon, Inc. Dispensing paste for forming medicinal pellets
US4748024A (en) * 1987-04-06 1988-05-31 Endocon, Inc. Flash flow fused medicinal implants
DE3851145T2 (de) * 1987-04-06 1994-12-15 Aberlyn Capital Management Par Durch schnellschmelzen hergestellte medizinische implantate.
US5019400A (en) * 1989-05-01 1991-05-28 Enzytech, Inc. Very low temperature casting of controlled release microspheres
DE69005800T2 (de) * 1989-05-01 1994-05-19 Alkermes Inc Verfahren zur herstellung von kleinen partikeln von biologisch aktiven molekülen.

Also Published As

Publication number Publication date
FI925661A0 (fi) 1992-12-11
ATE109658T1 (de) 1994-08-15
ES2059142T3 (es) 1994-11-01
CS181691A3 (en) 1992-06-17
CA2085344A1 (en) 1991-12-15
PT97975A (pt) 1992-04-30
NO302998B1 (no) 1998-05-18
BG61179B1 (bg) 1997-02-28
US5633014A (en) 1997-05-27
PT97975B (pt) 1998-11-30
FR2663223B1 (fr) 1994-12-02
US5512303A (en) 1996-04-30
AU8084791A (en) 1992-01-07
CN1057961A (zh) 1992-01-22
FI925661A (fi) 1992-12-11
PL167234B1 (pl) 1995-08-31
RU2104692C1 (ru) 1998-02-20
DE69103419D1 (de) 1994-09-15
SK280564B6 (sk) 2000-03-13
CA2085344C (en) 1998-06-30
CZ286793B6 (cs) 2000-07-12
DE69103419T2 (de) 1995-03-30
FI107698B (fi) 2001-09-28
JP2675675B2 (ja) 1997-11-12
NO924792L (no) 1993-02-03
BR9106545A (pt) 1993-06-01
IL98459A (en) 1996-09-12
EP0533739B1 (fr) 1994-08-10
WO1991019484A1 (fr) 1991-12-26
UA27043C2 (uk) 2000-02-28
IL98459A0 (en) 1992-07-15
IE62679B1 (en) 1995-02-22
HU9203958D0 (en) 1993-03-29
PL290677A1 (en) 1992-11-30
CN1057442C (zh) 2000-10-18
AU661275B2 (en) 1995-07-20
NO924792D0 (no) 1992-12-11
IE912017A1 (en) 1991-12-18
KR0157439B1 (ko) 1998-11-16
ZA914550B (en) 1992-03-25
HUT68709A (en) 1995-07-28
JPH05507694A (ja) 1993-11-04
NZ238542A (en) 1993-09-27
FR2663223A1 (fr) 1991-12-20
BG97166A (bg) 1993-12-24
TNSN91048A1 (fr) 1992-10-25
EP0533739A1 (fr) 1993-03-31
DK0533739T3 (da) 1995-01-09
US5360616A (en) 1994-11-01

Similar Documents

Publication Publication Date Title
UY23240A1 (es) Procedimiento para la preparacion de una composicion farmaceutica inyectable
ES2170259T3 (es) Empleo de lipidos como agentes auxiliares en la obtencion de formas farmaceuticas solidas segun el procedimiento de extrusion en fusion.
ES2052550T3 (es) 9-alfa-hidroxiesteroides, procedimiento para su preparacion y procedimiento para la preparacion de los correspondientes derivados 9(11)-deshidro.
BR9916741A (pt) Nanocápsulas e procedimento para fabricação destas
KR870700344A (ko) 유효 화합물을 서서히 방출하는 신규 약제, 그의 제조방법 및 이신규 제제물의 용도
ES2110230T3 (es) Ensayo de rapamicina.
UA42062C2 (uk) Трифазова фармацевтична форма з постійним і контрольованим виділенням аморфного активного інгредієнта та спосіб її виготовлення
AR006012A1 (es) Tabletas que contienen antibioticos de beta-lactamas y un metodo para obtenerlas
SE9600820D0 (sv) Antibodies and their use
ES2094781T3 (es) Composicion farmaceutica de microparticulas con liberacion controlada y su proceso de preparacion.
PT1283700E (pt) Composicoes farmaceuticas de libertacao prolongada destinadas a administracao por via parental de compostos hidrofilos biologicamente activos
ME00243B (me) Kristalni monohidrat, postupak za njegovo pripremanje i njegova primena za pripremanje lijeka
AR013947A1 (es) Composicion farmaceutica para combinacion de piperidinoalcanol- descongestionante
ES2185238T3 (es) Preparado oral de itraconazol y su procedimiento de preparacion.
KR860002270A (ko) 니트렌디핀을 함유하는 고상 약제 및 그의 제조방법
BG95911A (bg) Лекарствена парентерална форма с депо действие
PE27899A1 (es) Formulacion de particulas revestidas
IT8847814A0 (it) Impieghi in terapeutica degli agonisti dei recettori dopaminergici
RU2004133532A (ru) Фармацевтические препараты с замедленным высвобождением и способы их получения
BR0009927A (pt) Método para produzir uma matriz de liberação controlada, amórfica ou parcialmente amórfica insolúvel em água
CU22723A1 (es) Mezcla de ácidos grasos primarios de alto peso molecular obtenidos de la cera de cana de azúcar y sus usos farmacéuticos
CO5190673A1 (es) Nueva composicion y uso liberacion modificada
DE69512638D1 (de) Schnell auflösende orale darreichungsform
BR0016177A (pt) Espuma em fios ocos e preparação da mesma
BR9405400A (pt) Baliza dobrável e transportável, para sinalização viária, de emergência em via pública e outros usos

Legal Events

Date Code Title Description
VENC Patent expired

Effective date: 20140527